Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition.

Harvey M, Prosser LA, Rose AM, Ortega-Sanchez IR, Harpaz R.

Pain. 2019 Oct 9. doi: 10.1097/j.pain.0000000000001718. [Epub ahead of print]

PMID:
31599852
2.

Costs associated with acute respiratory illness and select virus infections in hospitalized children, El Salvador and Panama, 2012-2013.

Jara JH, Azziz-Baumgartner E, De Leon T, Luciani K, Brizuela YS, Estripeaut D, Castillo JM, Barahona A, Corro M, Cazares R, Vergara O, Rauda R, González R, Franco D, Widdowson MA, Clará W, Alvis-Estrada JP, Murray CT, Ortega-Sanchez IR, Dawood FS.

J Infect. 2019 Aug;79(2):108-114. doi: 10.1016/j.jinf.2019.05.021. Epub 2019 May 31.

3.

A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations.

Prosser LA, Harpaz R, Rose AM, Gebremariam A, Guo A, Ortega-Sanchez IR, Zhou F, Dooling K.

Ann Intern Med. 2019 Mar 19;170(6):380-388. doi: 10.7326/M18-2347. Epub 2019 Feb 19.

PMID:
30776797
4.

Cost of Public Health Response and Outbreak Control With a Third Dose of Measles-Mumps-Rubella Vaccine During a University Mumps Outbreak-Iowa, 2015-2016.

Marin M, Kitzmann TL, James L, Quinlisk P, Aldous WK, Zhang J, Cardemil CV, Galeazzi C, Patel M, Ortega-Sanchez IR.

Open Forum Infect Dis. 2018 Oct 4;5(10):ofy199. doi: 10.1093/ofid/ofy199. eCollection 2018 Oct.

5.

Costs of hospitalization with respiratory syncytial virus illness among children aged <5 years and the financial impact on households in Bangladesh, 2010.

Bhuiyan MU, Luby SP, Alamgir NI, Homaira N, Sturm-Ramirez K, Gurley ES, Abedin J, Zaman RU, Alamgir A, Rahman M, Ortega-Sanchez IR, Azziz-Baumgartner E.

J Glob Health. 2017 Jun;7(1):010412. doi: 10.7189/jogh.07.010412.

6.

Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016.

MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IR, Martin SW.

MMWR Morb Mortal Wkly Rep. 2016 Nov 4;65(43):1189-1194. doi: 10.15585/mmwr.mm6543a3.

7.

Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.

MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW.

MMWR Morb Mortal Wkly Rep. 2015 Oct 23;64(41):1171-6. doi: 10.15585/mmwr.mm6441a3.

8.

Clinical and economic impact of various strategies for varicella immunity screening and vaccination of health care personnel.

Baracco GJ, Eisert S, Saavedra S, Hirsch P, Marin M, Ortega-Sanchez IR.

Am J Infect Control. 2015 Oct 1;43(10):1053-60. doi: 10.1016/j.ajic.2015.05.027. Epub 2015 Jun 30.

PMID:
26138999
9.

Cost of measles containment in an ambulatory pediatric clinic.

Wendorf KA, Kay M, Ortega-Sanchez IR, Munn M, Duchin J.

Pediatr Infect Dis J. 2015 Jun;34(6):589-93. doi: 10.1097/INF.0000000000000682.

PMID:
25973936
10.

Congenital cytomegalovirus-related hospitalizations in infants <1 year of age, United States, 1997-2009.

Lopez AS, Ortega-Sanchez IR, Bialek SR.

Pediatr Infect Dis J. 2014 Nov;33(11):1119-23. doi: 10.1097/INF.0000000000000421.

11.

Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection.

Lanzieri TM, Bialek SR, Ortega-Sanchez IR, Gambhir M.

Vaccine. 2014 Jun 24;32(30):3780-6. doi: 10.1016/j.vaccine.2014.05.014. Epub 2014 May 14.

12.

Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010.

Kutty PK, Lawler J, Rausch-Phung E, Ortega-Sanchez IR, Goodell S, Schulte C, Pollock L, Valure B, Hudson J, Gallagher K, Blog D.

Hum Vaccin Immunother. 2014;10(5):1373-81. doi: 10.4161/hv.28389. Epub 2014 Mar 14.

13.

The economic burden of sixteen measles outbreaks on United States public health departments in 2011.

Ortega-Sanchez IR, Vijayaraghavan M, Barskey AE, Wallace GS.

Vaccine. 2014 Mar 5;32(11):1311-7. doi: 10.1016/j.vaccine.2013.10.012. Epub 2013 Oct 14.

14.

Rotavirus-associated hospitalization and emergency department costs and rotavirus vaccine program impact.

Kilgore A, Donauer S, Edwards KM, Weinberg GA, Payne DC, Szilagyi PG, Rice M, Cassedy A, Ortega-Sanchez IR, Parashar UD, Staat MA.

Vaccine. 2013 Aug 28;31(38):4164-71. doi: 10.1016/j.vaccine.2013.06.085. Epub 2013 Jul 8.

15.

Effect of winter school breaks on influenza-like illness, Argentina, 2005-2008.

Garza RC, Basurto-Dávila R, Ortega-Sanchez IR, Carlino LO, Meltzer MI, Albalak R, Balbuena K, Orellano P, Widdowson MA, Averhoff F.

Emerg Infect Dis. 2013 Jun;19(6):938-44. doi: 10.3201/eid1906.120916.

16.

Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2013 Mar 22;62(RR-2):1-28.

17.

Economic impact of the 2009-2010 Guam mumps outbreak on the public health sector and affected families.

Mahamud A, Fiebelkorn AP, Nelson G, Aguon A, McKenna J, Villarruel G, Gallagher K, Ortega-Sánchez IR.

Vaccine. 2012 Oct 5;30(45):6444-8. doi: 10.1016/j.vaccine.2012.08.001. Epub 2012 Aug 14.

PMID:
22902678
18.

Indirect, out-of-pocket and medical costs from influenza-related illness in young children.

Ortega-Sanchez IR, Molinari NA, Fairbrother G, Szilagyi PG, Edwards KM, Griffin MR, Cassedy A, Poehling KA, Bridges C, Staat MA.

Vaccine. 2012 Jun 13;30(28):4175-81. doi: 10.1016/j.vaccine.2012.04.057. Epub 2012 Apr 27.

PMID:
22546332
19.

Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.

Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA.

Drugs. 2012 Jan 1;72(1):35-48. doi: 10.2165/11597310-000000000-00000. Review.

PMID:
22191794
20.

Health care-associated measles outbreak in the United States after an importation: challenges and economic impact.

Chen SY, Anderson S, Kutty PK, Lugo F, McDonald M, Rota PA, Ortega-Sanchez IR, Komatsu K, Armstrong GL, Sunenshine R, Seward JF.

J Infect Dis. 2011 Jun 1;203(11):1517-25. doi: 10.1093/infdis/jir115. Epub 2011 Apr 28.

PMID:
21531693
21.

Needlestick injuries among sanitation workers in Mexico City.

Thompson B, Moro PL, Hancy K, Ortega-Sánchez IR, Santos-Preciado JI, Franco-Paredes C, Weniger BG, Chen RT.

Rev Panam Salud Publica. 2010 Jun;27(6):467-8. No abstract available.

PMID:
20721448
22.

High costs of influenza: Direct medical costs of influenza disease in young children.

Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, Edwards KM, Molinari NA, Donauer S, Henderson D, Ambrose S, Kent D, Poehling K, Weinberg GA, Griffin MR, Hall CB, Finelli L, Bridges C, Staat MA; New Vaccine Surveillance Network (NVSN).

Vaccine. 2010 Jul 12;28(31):4913-9. doi: 10.1016/j.vaccine.2010.05.036. Epub 2010 May 31.

PMID:
20576536
23.

Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated.

Sugerman DE, Barskey AE, Delea MG, Ortega-Sanchez IR, Bi D, Ralston KJ, Rota PA, Waters-Montijo K, Lebaron CW.

Pediatrics. 2010 Apr;125(4):747-55. doi: 10.1542/peds.2009-1653. Epub 2010 Mar 22.

PMID:
20308208
24.

Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.

Lieu TA, Ray GT, Ortega-Sanchez IR, Kleinman K, Rusinak D, Prosser LA.

Pharmacoeconomics. 2009;27(12):1005-16. doi: 10.2165/11314000-000000000-00000.

PMID:
19908925
25.

MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approach.

Cho BH, Clark TA, Messonnier NE, Ortega-Sanchez IR, Weintraub E, Messonnier ML.

Vaccine. 2010 Jan 8;28(3):817-22. doi: 10.1016/j.vaccine.2009.10.050. Epub 2009 Oct 30.

PMID:
19879992
26.

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4.

27.

An economic analysis of the universal varicella vaccination program in the United States.

Zhou F, Ortega-Sanchez IR, Guris D, Shefer A, Lieu T, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S156-64. doi: 10.1086/522135.

PMID:
18419391
28.

Varicella outbreak reporting, response, management, and national surveillance.

Leung J, Rue A, Lopez A, Ortega-Sanchez IR, Harpaz R, Guris D, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S108-13. doi: 10.1086/522138.

PMID:
18419382
29.

Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement--Maine, 2006.

Parker AA, Reynolds MA, Leung J, Anderson M, Rey A, Ortega-Sanchez IR, Schmid DS, Guris D, Gensheimer KF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S101-7. doi: 10.1086/522134.

PMID:
18419381
30.

Economics of cardiac adverse events after smallpox vaccination: lessons from the 2003 US Vaccination Program.

Ortega-Sanchez IR, Sniadack MM, Mootrey GT.

Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S168-78. doi: 10.1086/524380.

PMID:
18284356
31.

Projected cost-effectiveness of new vaccines for adolescents in the United States.

Ortega-Sanchez IR, Lee GM, Jacobs RJ, Prosser LA, Molinari NA, Zhang X, Baine WB, McCauley MM, Miller T; Working Group on Leading Economic Issues for New Vaccine for Adolescents.

Pediatrics. 2008 Jan;121 Suppl 1:S63-78. doi: 10.1542/peds.2007-1115H. Review.

PMID:
18174323
32.

Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.

Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, Zhang X, Stephens DS, Messonnier NE; Active Bacterial Core Surveillance Team.

Clin Infect Dis. 2008 Jan 1;46(1):1-13. doi: 10.1086/524041.

PMID:
18171206
33.

The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB.

Vaccine. 2007 Jun 28;25(27):5086-96. Epub 2007 Apr 20.

PMID:
17544181
34.

Two nosocomial pertussis outbreaks and their associated costs - King County, Washington, 2004.

Baggett HC, Duchin JS, Shelton W, Zerr DM, Heath J, Ortega-Sanchez IR, Tiwari T.

Infect Control Hosp Epidemiol. 2007 May;28(5):537-43. Epub 2007 Mar 22.

PMID:
17464912
35.

Economics of immunization information systems in the United States: assessing costs and efficiency.

Bartlett DL, Molinari NA, Ortega-Sanchez IR, Urquhart GA.

Cost Eff Resour Alloc. 2006 Aug 22;4:15.

36.

Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States.

Parker AA, Staggs W, Dayan GH, Ortega-Sánchez IR, Rota PA, Lowe L, Boardman P, Teclaw R, Graves C, LeBaron CW.

N Engl J Med. 2006 Aug 3;355(5):447-55. Erratum in: N Engl J Med. 2006 Sep 14;355(11):1184.

37.

Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers.

Calugar A, Ortega-Sánchez IR, Tiwari T, Oakes L, Jahre JA, Murphy TV.

Clin Infect Dis. 2006 Apr 1;42(7):981-8. Epub 2006 Feb 15.

PMID:
16511764
38.

The cost of containing one case of measles: the economic impact on the public health infrastructure--Iowa, 2004.

Dayan GH, Ortega-Sánchez IR, LeBaron CW, Quinlisk MP; Iowa Measles Response Team.

Pediatrics. 2005 Jul;116(1):e1-4.

PMID:
15995008
39.

Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.

Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE; ABCs Team.

Pediatrics. 2005 May;115(5):1220-32.

PMID:
15867028

Supplemental Content

Loading ...
Support Center